Literature DB >> 24772161

Systemic lupus erythematosis with severe aplastic anemia successfully treated with rituximab and antithymocyte globulin.

Wenbin Liu1, Zhiping Hu2, Shengyun Lin3, Jianghua He4, Yuhong Zhou5.   

Abstract

Hematologic disorders are very common in Systmic lupus erythematosus (SLE).First presentation of SLE with severe aplastic anemia (SAA) is extremely rare. We report a patient with the diagnosis of secondary SAA associated with SLE. Conventional therapy was not effective. She received Rituximab (RTX) and Antithymocyte globulin (ATG) therapy, her response was satisfactory finally. Her hematologic parameters were within normal ranges until last follow-up, eight months and six months after therapy was initiated with RTX and ATG, respectively. This is the first time RTX and ATG were successfully used in the treatment of SAA secondary to SLE.

Entities:  

Keywords:  Antithymocyte globulin; Aplastic anemia; Rituximab; Systmic lupus erythematosus

Year:  2014        PMID: 24772161      PMCID: PMC3999028     

Source DB:  PubMed          Journal:  Pak J Med Sci        ISSN: 1681-715X            Impact factor:   1.088


  10 in total

Review 1.  Pathogenesis of lupus.

Authors:  Kurt Oelke; Bruce Richardson
Journal:  Arthritis Rheum       Date:  2002-06-15

Review 2.  The initial presentation of systemic lupus erythematosis with aplastic anemia successfully treated with rituximab.

Authors:  Gholam-Hossein Alishiri; Amin Saburi; Noushin Bayat; Ali-Reza Saadat; Ehsan Saburi
Journal:  Clin Rheumatol       Date:  2011-10-21       Impact factor: 2.980

3.  Intrinsic impairment of CD4(+)CD25(+) regulatory T cells in acquired aplastic anemia.

Authors:  Jun Shi; Meili Ge; Shihong Lu; Xingxin Li; Yingqi Shao; Jinbo Huang; Zhendong Huang; Jing Zhang; Neng Nie; Yizhou Zheng
Journal:  Blood       Date:  2012-07-13       Impact factor: 22.113

Review 4.  Current concepts in the pathophysiology and treatment of aplastic anemia.

Authors:  Neal S Young; Rodrigo T Calado; Phillip Scheinberg
Journal:  Blood       Date:  2006-06-15       Impact factor: 22.113

5.  Long-term efficacy and safety of rituximab in refractory and relapsing systemic lupus erythematosus.

Authors:  Fausta Catapano; Afzal N Chaudhry; Rachel B Jones; Kenneth G C Smith; David W Jayne
Journal:  Nephrol Dial Transplant       Date:  2010-05-11       Impact factor: 5.992

Review 6.  The management of peripheral blood cytopenias in systemic lupus erythematosus.

Authors:  Alastair L Hepburn; Santosh Narat; Justin C Mason
Journal:  Rheumatology (Oxford)       Date:  2010-09-07       Impact factor: 7.580

Review 7.  B cell-directed therapies for autoimmune disease and correlates of disease response and relapse.

Authors:  Marc C Levesque; E William St Clair
Journal:  J Allergy Clin Immunol       Date:  2008-01       Impact factor: 10.793

8.  Cutting edge: Regulatory T cells directly suppress B cells in systemic lupus erythematosus.

Authors:  Noriko Iikuni; Elaine V Lourenço; Bevra H Hahn; Antonio La Cava
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

9.  Thrombocytopenia and thromboembolism in pediatric systemic lupus erythematosus.

Authors:  Markus Schmugge; Shoshana Revel-Vilk; Linda Hiraki; Margaret L Rand; Victor S Blanchette; Earl D Silverman
Journal:  J Pediatr       Date:  2003-11       Impact factor: 4.406

Review 10.  Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses.

Authors:  Shimon Sakaguchi
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

  10 in total
  2 in total

Review 1.  Lessons learned from bone marrow failure in systemic lupus erythematosus: Case reports and review of the literature.

Authors:  Erik Anderson; Bhakti Shah; Anne Davidson; Richard Furie
Journal:  Semin Arthritis Rheum       Date:  2017-12-08       Impact factor: 5.532

2.  Outcomes of rituximab therapy in refractory lupus: A meta-analysis.

Authors:  Fatma Alshaiki; Elaf Obaid; Abdulqader Almuallim; Rabab Taha; Hadeel El-Haddad; Hani Almoallim
Journal:  Eur J Rheumatol       Date:  2018-02-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.